A groundbreaking ultra-low magnetic scanner developed by scientists at the University of Aberdeen could revolutionize breast cancer diagnosis and treatment. The Field Cycling Imager (FCI) outperforms current MRI methods by accurately differentiating tumor material from healthy tissue, potentially reducing the need for repeat surgeries after lumpectomies. Dr. Lionel Broche, a lead researcher, stated that the FCI scanner offers a more precise identification of tumors, which could significantly enhance treatment plans. The FCI technology does not require dye injections, minimizing risks associated with traditional imaging techniques. With promising preliminary results, researchers are optimistic about its future applications in clinical settings. The findings were published in Nature Communications Medicine.
Wed, 26 Feb 2025 14:11:00 GMT | Corydon Times